U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812455) titled 'Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization' on Feb. 02.
Brief Summary: The purpose of the RIVA-RAO study is to determine whether the use of Rivaroxaban is an effective treatment of radial artery occlusion (RAO) after cardiac catheterization (both angiography and PCI). This is a prospective, single-center, randomized controlled, open-label study that will randomize patients with RAO into two groups, one receiving Rivaroxaban and the other receiving no anticoagulation. RAO will be detected by radial artery ultrasound up to 24 hours after the procedure.
Study objectives:
Primary objective:...